Professional Seasonal Analysis for Trading

Adaptive Biotechnologies Corporation - Common Stock (ADPT)

Seasonality Analysis

Stocks 7 Years Analyzed

Adaptive Biotechnologies Corporation - Common Stock Annual Seasonality Statistics

6.18%
Avg Annual Return
50.6%
Avg Monthly Win Rate
6/12
Positive Months
7
Years Analyzed

Adaptive Biotechnologies Corporation - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January -0.17%
57%
Weak
February -4.17%
43%
Weak
March WORST -9.04%
29%
Very Weak
April -8.51%
43%
Weak
May 10.71%
50%
Weak
June BEST 13.23%
86%
Very Strong
July 2.75%
43%
Weak
August 6.93%
57%
Moderate
September -6.16%
43%
Weak
October -1.63%
43%
Weak
November 0.58%
57%
Moderate
December 1.67%
57%
Moderate

Adaptive Biotechnologies Corporation - Common Stock 2026 vs Historical Pattern

Current Position
33.72
Historical Avg Position
30.11
Deviation
+3.61
Performance
On Track

Adaptive Biotechnologies Corporation - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for ADPT with overlay patterns, custom date ranges, and more.

Create Free Account

Adaptive Biotechnologies Corporation - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Adaptive Biotechnologies Corporation - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for ADPT across multiple timeframes.

Create Free Account

About Adaptive Biotechnologies Corporation - Common Stock (ADPT) Seasonality

Adaptive Biotechnologies Corporation - Common Stock (ADPT) has been analyzed using 7 years of historical data to identify seasonal patterns. Classified under Stocks, Adaptive Biotechnologies Corporation - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Adaptive Biotechnologies Corporation - Common Stock is historically June, with an average return of 13.23% and a win rate of 86%. Conversely, March tends to be the weakest month, averaging -9.04% return.

Looking at the full calendar year, Adaptive Biotechnologies Corporation - Common Stock has an average annual return of 6.18% with an overall monthly win rate of 50.6%. Out of 12 months, 6 typically show positive average returns.

The seasonal pattern for Adaptive Biotechnologies Corporation - Common Stock has a consistency score of 50.6 (Fair), based on 8 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Adaptive Biotechnologies Corporation - Common Stock Seasonality FAQ

What is the best month to buy Adaptive Biotechnologies Corporation - Common Stock (ADPT)?

Historically, June has been the best month for Adaptive Biotechnologies Corporation - Common Stock, with an average return of 13.23% and a win rate of 86%. However, past performance does not guarantee future results.

What is the worst month for Adaptive Biotechnologies Corporation - Common Stock (ADPT)?

Based on historical data, March has been the weakest month for Adaptive Biotechnologies Corporation - Common Stock, with an average return of -9.04%. This is a historical observation and does not guarantee future results.

How reliable is ADPT seasonality data?

The seasonality analysis for Adaptive Biotechnologies Corporation - Common Stock is based on 7 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Adaptive Biotechnologies Corporation - Common Stock seasonality in my trading?

Use Adaptive Biotechnologies Corporation - Common Stock (ADPT) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.